Prices of Immunosuppressants drop in India

There is finally some good news for transplant patients in India. The National Pharmacuetical pricing authority of India has reduced some of the cost of major immunosuppresants by almost 20-50%. The most important among these is Prograf and Pangraf one of the main immunosuppresant for Kidney Transplant Patients.

The cost of dailysis, transplant and the follow up medicine is too prohibitve for many Indian patients. further low education and awareness levels contributed to patients skipping medicine to save money or taking them only every altrernate day. A lot others preffered to stay on dailysis due to not being able to afford the cost of transplant and better medicines.

While the cost of Tacrolimus has been dractically reduced the other drugs by Roche and Novartis haven't seen as much reduction. We hope the government will be able to bring down the price of all the drugs and blood tests realted to transplant and give a huge boost to organ donation in India.

Fruther more cost of Predisone, certain Insulins and Amoxycillin have to been reduced. A detailed pdf can be found here .

#kidneytransplant #organdonationindia #prograf #novartis #roche #astellas #NPPA India

Comments

Pancreatic Rest - The cure to Diabetes type 2

Shocked? Well apparently the cure to Diabetes Mellitus or Type 2 Diabetes has been in front of our eyes all along. Type 2 diabetes, is a condition where the body fails to regulate the sugar levels in the blood causes too much or too little insulin to be produced by the pancreas. It usually turns into a life long disease requiring diet control and insulin therapy. According to new research, conducted at McMaster university in Canada, there may be hope for type 2 suffers through an intensive program that involves closely monitoring of diet+exercises+insulin+oral medicines. It basically involves giving rest to your pancreas after which your pancreases returns to normal (according to 40% of the results of study) and you are cured of diabetes or your diabetes is reversed, atleast temporarily. Here are some of the numbers as shared by McMaster University Research Program: 41% of the participants saw their diabetes reverse in just four months after the intensive program. The trial...

Why the new Mental Health bill is being hailed by everyone in India right now

Mental health in India has always been greatly stigmatized. We are extremely judgmental of people who say they are depressed and approach a psychiatrist for the same. We talk behind their back and generally brand them as 'mental case'. It wasn't until recently Deepika Padukone followed by a number of other celebs disclosed being depressed and having various mental ailments that to some level it seems that we have reached a stage where we can atleast have a conversation about it. Recently the mental health care bill of 2013 was passed, that updated a lot of definitions of what constitutes mental health. It has been hailed by the general public as a step in the right direction. Here are some of the salient features of the bill that have really been appreciated by everyone. 1. First and most importantly, the mental health bill decriminalizes suicide. Viewed as a revolutionary move, the bill acknowledges the various mental factors contributing to a person...

NPPA India slashes Cancer drugs price

Nation Pharmaceutical Pricing Authority (NPPA) has been on a roll - first reducing the cost of life saving drugs and then reducing the cost of stents in India. Championing the cause of affordable medicine further, NPAA has further reduced the cost life saving cancer drugs, some by as much as 85%. The drugs include Iressa of AstraZeneca Pharma India, whose price has been bought down from Rs 29,259 to Rs 3,977, a reduction of 86 per cent and Dr Reddy's laboratories' Grafeel - the price of which has been slashed by 41 per cent, it said. The reduction is in the price range of 86 per cent to 13 per cent, NPPA said. The other pharma players the prices of whose cancer medicines have been reduced are Natco Pharma and Emcure pharmaceuticals among others, it added. In the diabetes segment also, there has been reduction in prices of the drugs, the regulator said. Source (Times of India)

Mediwikileaks

Search This Blog